Profile data is unavailable for this security.
About the company
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products. Its products are mainly sold under the brand names of Changlong and Qing Tong. Its primary products include tablets, capsules, bulk drug, membrane, pills, bulk drug, powder for injection, lyophilized powder for injection, small volume parenteral solutions, sterile bulk drug and solution. The Company is also engaged in the trading of biochemical medicine through its subsidiaries. Its principal subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited and Jilin Province Medicinal Plants Trading Company Limited.
- Revenue in HKD (TTM)910.61m
- Net income in HKD160.37m
- Incorporated1996
- Employees848.00
- LocationJilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
- Phone+86 4 358218333
- Fax+86 4 358210005
- Websitehttp://www.jlchanglong.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tianda Pharmaceuticals Ltd | 532.09m | -24.16m | 559.01m | 863.00 | -- | 0.9442 | 43.92 | 1.05 | -0.0112 | -0.0112 | 0.2475 | 0.2754 | 0.5306 | 4.88 | 4.37 | 616,557.40 | -2.49 | -- | -3.84 | -- | 48.02 | -- | -4.70 | -- | 0.8907 | -10.16 | 0.161 | -- | -- | -- | -- | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 612.03m | -39.25m | 644.96m | 1.15k | -- | 1.06 | -- | 1.05 | -0.0526 | -0.0526 | 0.8138 | 0.8131 | 0.4199 | 1.95 | 8.36 | 533,126.20 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Sirnaomics Ltd | 0.00 | -615.13m | 645.02m | 145.00 | -- | 2.05 | -- | -- | -8.09 | -8.09 | 0.00 | 3.59 | 0.00 | -- | -- | 0.00 | -70.91 | -- | -71.22 | -- | -- | -- | -- | -- | -- | -- | 0.6176 | -- | -- | -- | 10.88 | -- | -- | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 677.16m | 1.06k | 40.55 | 0.3321 | 4.34 | 0.6431 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Pak Fah Yeow International Ltd | 259.16m | 105.04m | 701.19m | 102.00 | 6.68 | 0.9164 | 6.24 | 2.71 | 0.337 | 0.337 | 0.8316 | 2.46 | 0.2995 | 2.88 | 22.18 | 2,540,765.00 | 12.14 | 3.99 | 12.60 | 4.18 | 84.45 | 80.79 | 40.53 | 21.27 | 6.90 | 10.08 | 0.0062 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Genor Biopharma Holdings Ltd | 0.00 | -729.71m | 712.42m | 104.00 | -- | 0.5443 | -- | -- | -1.44 | -1.44 | 0.00 | 2.55 | 0.00 | 0.00 | -- | 0.00 | -37.91 | -55.46 | -44.02 | -63.73 | -- | 66.56 | -- | -14,819.18 | 5.38 | -- | 0.006 | -- | -100.00 | -- | 7.65 | -- | -48.85 | -- |
| Antengene Corporation Ltd | 72.83m | -628.88m | 715.38m | 201.00 | -- | 0.5762 | -- | 9.82 | -1.02 | -1.02 | 0.1184 | 1.84 | 0.0358 | 0.9773 | 3.41 | 362,332.80 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
| JW (Cayman) Therapeutics Co Ltd | 188.12m | -831.03m | 775.24m | 398.00 | -- | 0.4233 | -- | 4.12 | -2.02 | -2.02 | 0.4571 | 4.42 | 0.0704 | 1.68 | 65.54 | 472,675.40 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
| Transcenta Holding Limited | 58.27m | -500.53m | 824.75m | 215.00 | -- | 0.7397 | -- | 14.15 | -1.23 | -1.23 | 0.1432 | 2.56 | 0.0281 | 2.05 | 1.49 | 271,016.40 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -32.87 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 20.29m | -416.64m | 830.13m | 313.00 | -- | 0.3745 | -- | 40.92 | -0.766 | -0.766 | 0.0373 | 4.06 | 0.0075 | -- | 0.531 | 64,820.64 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 610.30m | 97.99m | 850.49m | 258.00 | 9.39 | 0.9069 | 5.72 | 1.39 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 910.61m | 160.37m | 868.39m | 848.00 | 5.41 | 0.5421 | 7.07 | 0.9536 | 0.2863 | 0.2863 | 1.63 | 2.86 | 0.3587 | 2.18 | 2.94 | 1,073,836.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Brii Biosciences Ltd | 667.64k | -189.18m | 948.75m | 128.00 | -- | 0.281 | -- | 1,421.06 | -0.2601 | -0.2601 | 0.0009 | 4.63 | 0.0002 | -- | -- | 5,215.93 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.22bn | 176.13m | 1.01bn | 2.64k | 5.63 | 0.8906 | 3.50 | 0.4555 | 0.208 | 0.208 | 2.62 | 1.31 | 1.12 | 2.53 | 10.54 | 839,215.00 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.18bn | 1.59k | 5.30 | 0.4947 | 2.98 | 0.7012 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| Hbm Holdings Ltd | 699.64m | 178.20m | 1.18bn | 177.00 | 6.35 | 1.21 | 5.53 | 1.69 | 0.2424 | 0.2424 | 0.9533 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,952,752.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
Data as of May 10 2024. Currency figures normalised to Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's reporting currency: Hong Kong Dollar HKD
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investments Internationalas of 30 Jun 2023 | 32.00k | 0.02% |
| Invesense Asset Management Ltd.as of 29 Feb 2024 | 0.00 | 0.00% |
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
